Permethrin Lotion

Quick links to important sections

Permethrin Lotion

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Permethrin Lotion

Quick Facts

Property Description
Active ingredient Permethrin (INN)
Form Lotion, Topical preparation
Pharmacological class Ectoparasiticide
Common use Infestation management
Origin Synthetic pyrethroid

What Type of Medicine is Permethrin Lotion?

Permethrin Lotion is a topical preparation that uses Permethrin as its single active ingredient. The compound is universally classified as an ectoparasiticide, a specialized pharmacological agent used to eliminate parasites that live externally on the human body surface. This classification broadly places the product in the category of effective treatments for parasitic infestation management. The medicine is provided in a lotion or cream dosage form, an aqueous or lipid-based emulsion intended solely for external administration.

Is Permethrin a Natural or Synthetic Compound?

Permethrin is a chemically engineered synthetic pyrethroid, meaning it is manufactured to replicate the core structure and potent activity of natural pyrethrins derived from chrysanthemum flowers. This synthetic origin ensures a high degree of chemical stability and consistent effectiveness. As a single-ingredient product, Permethrin is incorporated into the vehicle, a base specifically designed to ensure prolonged and uniform contact with the skin. The specific chemical properties of Permethrin limit its absorption into the human system, verifying that the medicine is designed for localized action on the surface organisms.

What is the General Purpose of Permethrin Lotion?

The essential purpose of Permethrin Lotion is to manage and resolve external parasitic problems by effectively eliminating the causative organisms. As a targeted ectoparasiticide, Permethrin acts as a neurotoxin on the parasite's nervous system. This focused mechanism involves disrupting sodium channels in their nerve cells, leading to constant excitation, which ultimately results in the definitive paralysis and subsequent death of the offending organisms. This targeted action allows the medicine to halt the life cycle of the infestation, providing a means of clearing the host of the multiplying parasitic population.

Regulatory References

  1. Permethrin Topical: MedlinePlus Drug Information

What side effects are possible with Permethrin Lotion?

Possible Side Effects and Safety Information

The safety profile for Permethrin Lotion is primarily characterized by localized reactions at the site of application, as documented in government regulatory sources.


Adverse Reaction Scope

The most frequently encountered effects are generally localized to the Skin and subcutaneous tissue disorders and are classified as Common in regulatory documents. These include a burning sensation, stinging sensation, and pruritus (itching). Other less frequent effects, classified as Uncommon, include tingling (paraesthesia), erythema (redness), and rash.

Classification Common Adverse Reactions
Common Burning sensation, stinging sensation, pruritus
Uncommon Erythema, rash, tingling sensation

Time-Related Patterns and Persistent Effects

Official labeling notes that reactions such as burning and tingling are typically transient and occur more frequently immediately following application. The product’s safety profile also specifies a time-related pattern where pruritus and rash may persist for up to four weeks after successful clearance of the parasite. This persistent itching is defined in official safety documents as a post-treatment phenomenon and is not necessarily an indication of treatment failure.


Serious Adverse Reactions and Safety Constraints

Adverse reactions classified in the Immune System Disorders include hypersensitivity reactions. Use of Permethrin Lotion is contraindicated in patients with a known hypersensitivity to the active ingredient, to any of the excipients, or to any other pyrethroids or pyrethrins, which are chemically related compounds. Furthermore, safety and effectiveness have been established for treatment in pediatric patients aged two months and older.

Overdose and Emergency Response

The official regulatory documentation for Permethrin Lotion primarily addresses overdose resulting from accidental oral ingestion of the topical formulation. Ingestion of the product is explicitly stated as carrying the risk of serious, life-threatening outcomes.

Feature Official Regulatory Statements
Documented Manifestations Symptoms following ingestion may include nausea, vomiting, headache, dizziness, and abdominal pain. Severe cases have the potential for central nervous system involvement, including convulsions.
Exposure Risk Overdose risk is constrained to accidental oral ingestion, as the lotion is not intended for consumption.
Antidote / Management No specific antidote is known. Management is entirely symptomatic and supportive. Regulatory guidance often states do not induce vomiting due to the presence of solvents, unless directed by emergency personnel.
Population Notes Management protocols may include specific procedures, such as the consideration of gastric lavage, when accidental ingestion involves a child.

When to Seek Immediate Medical Help

The product labeling mandates that individuals seek immediate medical attention for any suspected overdose or accidental ingestion. Contact a Poison Control center immediately. Emergency services (911 or equivalent) must be called if the individual is collapsed, unconscious, having trouble breathing, or experiencing convulsions or seizures, as these indicate a critical, life-threatening scenario.

Therapeutic Uses of Permethrin Lotion

What Permethrin Lotion Treats: Main Uses and Benefits

Permethrin Lotion is generally used for the treatment and resolution of two primary external parasitic conditions: scabies and pediculosis (lice infestations, including head and pubic lice). This therapeutic domain is applicable within clinical settings that involve the symptoms related to these mite and lice infestations. The fundamental therapeutic benefit may assist with the clearance of the causative organisms, which helps to manage the cycle that perpetuates the problem.

The medication is applied in addressing symptom clusters that may become intense or disruptive, particularly intense pruritus (itching), along with visible integumentary manifestations. By clearing the parasites, it provides supportive relief that helps ease the overall burden of skin irritation and contributes to improved comfort during symptomatic periods. The primary goal is the resolution of infestation to support the patient’s physical comfort. Permethrin is commonly used across relevant patient groups, including pediatric patients, adults, and older adults, and it is considered relevant for use in close contacts to support the management of potential transmission and recurrence.


Quick Fact: Relief for Intense Itching

Property Description
Primary Indication Scabies, Head Lice, Body Lice, Pubic Lice
Main Symptom Relieved Intense pruritus (itching)
Clinical Context First-line treatment for ectoparasite clearance
Patient Benefit Supports maintenance of functional stability and comfort

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Permethrin Lotion?

The official eligibility for Permethrin Lotion is defined by governmental regulatory documents, focusing primarily on absolute contraindications and minimum age restrictions.

Contraindicated Populations

Permethrin Lotion is absolutely contraindicated in any patient with a documented history of hypersensitivity to the active ingredient, Permethrin, to other synthetic pyrethroids or pyrethrins, or to any component of the specific formulation. This criterion is the primary formal exclusion.

Age-Group Eligibility

Population Regulatory Status
Adults and Older Adults Permitted for use under standard conditions.
Children (≥ 2 months) Approved for use.
Infants (< 2 months) Use is not established and is not recommended.

The 5% formulation is officially approved for individuals aged two months and older. Use in infants younger than two months is not established and requires alternative management.

Conditional Use and Restrictions

Use requires caution in patients with a history of asthma or allergy to chrysanthemum or ragweed due to the potential for cross-sensitivity. For pregnant or breastfeeding women, use is considered permissible only if clearly needed and should occur under medical guidance, often necessitating temporary cessation of breastfeeding as a precaution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for topical Permethrin is largely characterized by a lack of established systemic interactions. Due to its minimal absorption into the bloodstream (typically less than 2%), official government prescribing information confirms that no known interactions have been established with most systemic medicinal products. Furthermore, the official labeling states that there are no documented interactions with foods, drinks, or herbal products.

Interaction-Related Restrictions

The following two specific restrictions are documented in regulatory sources:

  1. Timing Separation Requirement:

    • The treatment of associated eczematous-like reactions with topical corticosteroids should be withheld immediately prior to applying Permethrin Lotion. This rule is a condition-based constraint imposed to prevent the possibility of exacerbating the scabies infestation.
  2. Excipient-Mediated Product Restriction:

    • The formulation of the lotion contains the excipient liquid paraffin. This substance can physically reduce the functional reliability of latex products, such as condoms and diaphragms, if used concurrently.

These restrictions confirm that regulatory concerns are limited to local topical management and physical product interactions rather than systemic drug-drug interactions.

Mechanism of Action

The mechanism of Permethrin's action is defined by a neurotoxic action on ectoparasites. It operates by modulating the kinetics of key ion channels within the parasite's nervous system, triggering a cascade that leads to the cessation of physiological function.

Molecular Targeting: Disruption of Sodium Channel Inactivation

Permethrin exerts its core action by specifically binding to Voltage-Gated Sodium Channels ( VGSCs) located in the nerve cell membranes of the target organism. This molecular interaction prevents the channels from closing (inactivation), leading to a prolonged and uncontrolled influx of sodium ions ( Na^+). This immediate physiological consequence initiates sustained electrical overstimulation of the parasitic neurons.

Mechanistic Cascade: Leading to Paralysis and System Failure

The sustained influx of Na^+ ions triggers a state of massive, repetitive neuronal firing, known as hyperexcitability, throughout the parasite's nervous system. This continuous electrical overdrive overwhelms the motor pathways, resulting in systemic paralysis of the organism. This physiological consequence is derived from Permethrin's neurotoxic mechanism.

Mechanism Limitation: Enzyme and Target-Site Resistance

The effectiveness of this mechanism can be physiologically constrained by two main forms of parasitic resistance: target-site insensitivity (mutations altering the VGSC binding site) and metabolic detoxification (increased activity of enzymes like Cytochrome P450, which break down Permethrin). These resistance pathways reduce the toxic concentration of Permethrin available to disrupt the sodium channels, limiting the full expression of the neurotoxic cascade.

Dosage and Administration Information

Permethrin is administered topically only, with the required strength determined by the target condition. This standardized use is structured as a short-term, single application with a specific retreatment schedule.


Administration Guidelines

Feature Rule
Route of administration Topical use only; the product is strictly for external application to the skin or the hair and scalp.
Dosing schedule 5% Cream (Scabies): Apply a single, thin layer to all skin surfaces from the neck to the soles of the feet. Up to 30 grams is usually sufficient for an average adult. 1% Lotion (Lice): Apply a sufficient amount to saturate the hair and scalp completely.
Age-group rules Approved for use in patients 2 months of age and older. For infants and older adults using the 5% cream, application must be extended to include the scalp, hairline, neck, and face.

Frequency and Procedural Conditions

Condition Frequency and Contact Time
Scabies (5% Cream) Single application is standard. The cream must be left on the skin for 8 to 14 hours before washing off. A second application may be given 14 days after the first if live mites are observed.
Lice (1% Lotion) Single application is standard. The lotion must be left on the hair for 10 minutes (no longer) before rinsing. A second treatment should be administered seven days or more after the initial application if live lice are still observed.

Special Procedural Conditions

Before using the 1% lotion for lice, the hair must be washed with a shampoo that does not contain a conditioner and then towel-dried until damp, as conditioner may decrease the product's activity. After treatment for lice, nit removal using a fine-toothed comb is part of the overall protocol.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Permethrin Lotion

Evidence for Use in Scabies Infestation

Research examined the 5% permethrin cream formulation in the context of scabies infestation, mainly through Randomized Controlled Trials (RCTs) and systematic reviews that compile the findings of multiple trials. These studies was set up to examine short-term changes in the condition, primarily measuring clinical clearance, which is defined by the absence of signs of active mites or new lesions observed two to four weeks after treatment. Researchers also monitored outcomes related to physical discomfort, such as changes in the intensity of severe itching (pruritus).

Findings from these studies describe patterns observed in the populations regarding the initial measured outcomes at the two-week mark in trials that included comparators. The evidence also contributes to understanding that patterns measured in longer observation periods have shown inconsistent findings across different studies, related to factors like follow-up duration and the specific criteria used. What is still uncertain is the long-term durability of the measured outcome; follow-up durations were limited in many of the primary studies, meaning data for recurrence over periods longer than four weeks are not fully established.


Evidence for Use in Lice Infestation (Pediculosis)

The research base for 1% permethrin formulations was studied for lice infestations (pediculosis), consisting mainly of Controlled Trials that compare permethrin to either a placebo or other lice treatments. These studies monitored the absence of live adult lice and viable eggs (nits), specifically measuring this outcome at defined observation intervals. Studies reported measurements of lice-killing activity at short-term follow-up points. Genetic surveillance studies have reported the presence of specific genetic changes, known as kdr mutations, in lice populations across the globe. These findings contribute to understanding symptom patterns by showing that a connection was observed in some studies between this genetic marker and treatment outcomes.


Evidence Gaps and Research Uncertainties

The main research limitation for 1% permethrin involves extensive documentation of lice populations that have shown reduced susceptibility to permethrin, linked to these genetic changes. The primary gap involves evolving parasite resistance, which is observed globally, particularly in head lice populations. Comparative evidence is lacking for permethrin against the newest therapeutic options now available. Finally, the full impact of variables like non-adherence and reinfection on the long-term measured outcomes of the product is difficult to isolate and quantify based on current trial designs.

Frequently Asked Questions (FAQ)

Common questions about Permethrin Lotion (FAQ)


Q: Is Permethrin Lotion available over the counter or does it require a prescription?

The regulatory status of Permethrin depends on its strength. According to official product labeling, the 1% formulation is generally approved for non-prescription (Over-the-Counter, or OTC) use. However, the 5% cream is typically designated as a prescription-only product in many regions, including the United States.


Q: Do regulatory agencies have specific warnings about using Permethrin Lotion while pregnant?

Permethrin is in the former FDA Pregnancy Category B. Official documents indicate that the drug is considered permissible for use during pregnancy only if clearly needed. As with many medications, use occurs under medical guidance.


Q: Are there any common household products or cosmetics that interact with Permethrin Lotion?

Official labeling generally states that no known interactions have been established with systemic products, foods, drinks, or herbal products. However, the excipient liquid paraffin, which is present in some formulations, can reduce the functional reliability of latex products, such as condoms and diaphragms, if the products are used concurrently.


Q: Why does the packaging mention re-treating after a certain number of days?

The retreatment schedule specified in the product's official guidelines is based on the life cycle of the parasite being treated. This timing is intended to target any organisms that may have hatched from eggs or survived the initial application. The goal is to maximize the probability of clearance of the infestation.


Q: What are the general guidelines about using Permethrin Lotion on a patient with asthma?

Official information indicates that use of Permethrin is considered to require caution in patients with a history of asthma or allergy to chrysanthemum or ragweed due to the potential for cross-sensitivity. Additionally, in some formulations, excipients like alcohol may be noted as potentially worsening asthma symptoms.


Q: Does Permethrin Lotion contain any ingredients derived from nuts or common allergens?

The inactive ingredients vary by specific formulation, but regulatory labels list excipients such as lanolin alcohols and fractionated coconut oil in some creams. The primary formal contraindication, according to official documents, is for patients with a known hypersensitivity to the active ingredient, synthetic pyrethroids, or pyrethrins.


Q: Is it possible for the condition treated by Permethrin Lotion to become resistant to it?

Regulatory documents and surveillance studies confirm that populations of lice have developed resistance to Permethrin in various geographic locations. This is linked to specific genetic changes in the parasites, which contributes to a reduced susceptibility to the product.


Q: Is the sensation of skin crawling after using Permethrin Lotion a common experience?

The official safety profile includes tingling (paresthesia) as a reported adverse effect. This sensation is described as a pricking or burning feeling on the skin. This effect is generally transient and may occur following application.


Q: How is the safety of Permethrin Lotion monitored by regulatory bodies after it's approved?

The safety of the product after approval is monitored through post-marketing reporting requirements mandated by regulatory bodies like the FDA. These regulations require manufacturers to actively track and report any unexpected or serious adverse experiences that occur once the drug is available to the public.


Q: What is the general recommendation for laundering clothing after using Permethrin Lotion?

Authoritative guidelines often recommend that bedding, clothing, hats, and towels used by the patient and close contacts should be washed in hot water or dry cleaned. This step is advised to help remove any remaining organisms and prevent the possibility of re-infestation.


Q: Can Permethrin Lotion be used for prevention, or only after diagnosis?

Permethrin Lotion is indicated for the management of infestation (treatment) after a diagnosis has been established. Some authoritative sources advise that using the product preventively on non-infected persons is ineffective and may increase the risk of resistance.


Q: Is Permethrin Lotion considered a neurotoxin in official medical descriptions?

In medical literature and summaries of its mechanism of action, Permethrin is described as a synthetic neurotoxic pyrethroid. This description refers to its focused action on the nervous system of the parasite to cause paralysis.


Q: Can Permethrin Lotion cause redness or irritation in people with sensitive skin?

Official labeling notes that common adverse reactions include temporary redness (erythema) and a burning or stinging sensation. The product's precautions indicate that treatment may temporarily exacerbate existing skin conditions, and official guidance notes that a healthcare provider should be consulted regarding any known skin sensitivities.


Q: Why is it important to treat close contacts of the person using Permethrin Lotion?

Authoritative guidelines indicate that effective management of the condition often requires the concurrent treatment of the patient and all close contacts. This is recommended regardless of whether the contacts show symptoms, to help prevent the re-infestation of the initially treated individual.


Q: What is the difference between Permethrin Lotion and permethrin creams or sprays?

Permethrin is available in different strengths and forms, such as the 1% lotion and the 5% cream. According to official product labeling, these different formulations are specifically indicated for different parasitic conditions.


Q: Can Permethrin Lotion be used on areas of the body other than where the rash is visible?

The official directions for use of the 5% cream require the product to be applied to all skin surfaces from the neck to the soles of the feet, not just the visibly affected areas. This comprehensive application is required to ensure coverage of the entire potential infestation site.


Q: Is it necessary to inform a pharmacist about all other topical products I use before getting Permethrin Lotion?

Official patient information advises informing a healthcare provider or pharmacist about all other prescription and nonprescription medicines, vitamins, supplements, and herbal products being used. This information is requested to ensure the safe and proper use of the medication.


Q: Why do official documents mention consulting a healthcare provider if the condition doesn't improve?

Official patient information advises consulting a healthcare provider if symptoms do not clear up within a specific timeframe or if live organisms are observed. This guidance is given because these issues may indicate treatment failure or require a second treatment.


Q: What evidence supports the use of Permethrin Lotion in infants?

Permethrin 5% cream is approved for patients aged two months and older. However, regulatory sources note that there is limited experience in children aged 2 to 23 months, and treatment in this group is sometimes recommended to occur under close medical supervision.


Q: Is there a different formulation of Permethrin for children versus adults?

Permethrin is available in different strengths, such as 1% and 5%. While the official guidelines adjust the application method for infants and older adults, they do not specify entirely different drug formulations based solely on age.


Q: Does Permethrin Lotion have any effect on lice or nits, not just scabies?

Permethrin is an ectoparasiticide that acts against a broad range of organisms. The 1% lotion is specifically indicated for treating lice and their unhatched eggs (nits), in addition to the 5% cream's use for scabies.


Q: What does the term 'licensed indication' mean for Permethrin Lotion?

The term 'licensed indication' refers to the specific parasitic conditions that a regulatory authority, such as the FDA or EMA, has formally approved the drug to treat. This approval is granted based on the submitted data and clinical research.


Q: Are there alternative treatment options for patients who cannot tolerate Permethrin Lotion?

Regulatory guidelines and medical literature for the conditions treated by Permethrin Lotion often reference other treatments, such as oral ivermectin or other topical products. These may be considered for patients who have contraindications or tolerance concerns with Permethrin.


Q: Can a patient use other moisturizing lotions or creams alongside Permethrin Lotion?

Official guidelines mention specific restrictions on the use of other topical products, such as avoiding conditioner before use of the 1% lotion and withholding topical corticosteroids immediately prior to the application of the 5% cream. No general restrictions are noted for all moisturizing lotions.


Q: What research exists regarding Permethrin Lotion's suitability for older adults?

While older adults are permitted for use under standard conditions, official guidelines note a key procedural difference: the 5% cream must be applied to the scalp, hairline, neck, and face for this age group. This adjusted application method addresses specific considerations for treating this population.

How should Permethrin Lotion be stored and disposed of?

Storage and Disposal of Permethrin Lotion

The storage and handling requirements for Permethrin 5% lotion are defined by regulatory labeling to maintain the product's integrity.

Storage Requirements

The lotion must be stored at controlled room temperature, typically between 15°C and 25°C (59°F and 77°F). It is required to be protected from freezing, as this condition can cause the emulsion to separate and compromise the product's quality. For safety, the medication must be kept in its original container, tightly closed, and stored out of the reach of children.

Disposal Instructions

Unused or expired Permethrin lotion should not be flushed down the toilet or poured into any drain. Consumers are instructed to check for community drug take-back programs or follow the specific guidelines provided by their local waste disposal authority for discarding unused pharmaceuticals.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Permethrin Lotion found in:

A-Z Index: